Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-05

Clinical Trial Update: Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing fimasartan to amlodipine for carotid plaque inflammation in patients with atherosclerotic disease and coronary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • Fimasartan (fimasartan)

Snippet

Sponsor: CHEOL WHAN LEE, M.D., Ph.D | Conditions: Inflammation Plaque, Atherosclerotic, Coronary Disease | Phase 4 | Status: COMPLETED